Related Experiment Video
Updated: Nov 5, 2025
05:37
An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
2.3K
Optimal treatment regimes for competing risk data using doubly robust outcome weighted learning with bi-level
Yizeng He1, Soyoung Kim1, Mi-Ok Kim2
1Division of Biostatistics, Medical College of Wisconsin, Milwaukee WI 53226, USA.
Computational Statistics & Data Analysis
|May 17, 2021
Summary
Personalized treatment maximizes benefits by considering patient and treatment factors. A new doubly robust method with adaptive penalties improves variable selection for competing risks, personalizing graft source choice in transplantation.
Area of Science:
- Biostatistics
- Health Services Research
- Medical Informatics
Background:
- Personalized treatment assignment aims to maximize patient benefits by tailoring interventions based on individual characteristics.
- Existing parametric regression methods struggle with complex outcome-treatment interactions and model misspecification, especially with competing risks.
- Parsimonious models are needed for clear interpretation and to prevent spurious predictor inclusion, yet these aspects are underdeveloped for competing risks data.
Purpose of the Study:
- To develop a robust and parsimonious statistical method for personalized treatment assignment in the presence of competing risks.
- To address the challenge of model misspecification and variable selection at both group and within-group levels for complex health outcomes.
- To personalize graft source selection in hematopoietic cell transplantation by accounting for patient-specific effects on treatment-related mortality.
Main Methods:
- Proposed a doubly robust estimation framework incorporating adaptive L1 penalties for variable selection.
- Applied the method to competing risks data, enabling selection of important variables at group and individual levels.
- Utilized hematopoietic cell transplantation data to demonstrate personalized graft source choice for treatment-related mortality.
Main Results:
- The proposed doubly robust method effectively selects relevant variables for personalized treatment assignment under competing risks.
- Analysis of hematopoietic cell transplantation data revealed that graft source effects on treatment-related mortality are patient-specific.
- Demonstrated that a one-size-fits-all approach to graft source selection is suboptimal, highlighting the importance of personalized medicine.
Conclusions:
- The developed method offers a robust and parsimonious approach for personalized treatment strategies in settings with competing risks.
- Personalized graft source selection in hematopoietic cell transplantation can significantly improve outcomes by considering patient heterogeneity.
- This work advances statistical methodologies for optimizing treatment decisions in complex clinical scenarios.
Related Concept Videos
01:20Comparing the Survival Analysis of Two or More Groups
376
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
376
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
218
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
218
01:15Assumptions of Survival Analysis
228
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
228
01:12Relative Risk
800
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
800
01:14Parametric Survival Analysis: Weibull and Exponential Methods
774
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
774
01:21Cancer Survival Analysis
493
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
493